Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.).

“As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy,” Makary wrote to Hawley.

“As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the Agency who review this data," he added in the letter.

Makary did not provide any further details about the forthcoming review since the abortion drug is a part of ongoing litigation.

Hawley has previously pressured the agency to review the drug. Last month, the senator sent a letter to Makary urging him to revie

See Full Page